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Summary.-Evidence is presented which indicates that S-(1,2,3,4-tetrahydro-2-
hydroxy-l-naphthyl)-L-cysteine (THN-cysteine), formed by the reaction of 1,2-
epoxy-THN with cysteine, can be incorporated into protein. The position of incor-
poration of THN-cysteine into protein would depend on whether the epoxide of
THN reacts with cysteinyl-tRNACYs or with cysteine. In both cases, the mechanism
of incorporation of THN-cysteine into protein is the same as for the natural amino
acids. For example, the incorporation of THN-cysteinyl-tRNACYs is stimulated
by Poly-UG, the code for tRNACys, and would be expected to be substituted for
cysteine in protein being synthesized, whereas THN-cysteine not previously
esterified to tRNA is activated by the isoleucyl- and valyl-RNA synthetases, and
its incorporation is stimulated by Poly-AU and Poly-UG, respectively. Conse-
quently, in this case, THN-cysteine would substitute for isoleucine and valine during
protein synthesis.
THE DIRECT binding of polycyclic
hydrocarbons to proteins has been well
established (Heidelberger, 1964), and the
possible role of such binding in the
process of carcinogenesis has been inferred
(Pitot and Heidelberger, 1963; Robinson
and Novelli, 1962; Jones et al., 1953;
Boyland and Sims, 1960). In a previous
report from our laboratory, a pathway
was described by which polycyclic hydro-
carbons, as conjugates of cysteine, ap-
peared to be incorporated into protein
via the mechanism utilized for amino
acid incorporation (Bucovaz et al., 1970).
S-(1,2, 3, 4-tetrahydro-2-hydroxy-1-naph-
thyl)-L-cysteine (THN-cysteine) and other
S-substituted cysteines were shown to
be activated, transferred to tRNA and
incorporated into protein. The position
of incorporation in the protein fabric
seemed to depend upon the structure of
the particular hydrocarbon conjugated
with cysteine (Bucovaz, Morrison and
Wood, 1966; Bucovaz and Wood, 1964;
Morrison et al., 1971). These findings,
together with the observation that S-
substituted arylcysteines can be syn-
thesized in tissues (Smith and Wood,
1959; Booth, Boyland and Sims, 1970)
as precursors for mercapturic acid forma-
tion (Mills and Wood, 1956; Stekol,
1939), offer a mechanism for the incor-
poration of aromatic hydrocarbons into
cellular proteins, alternative to direct
binding.
In this report, evidence is presented
that the mechanism for incorporation
of THN-cysteine into protein of baker's
yeast is identical to the conventional
mechanism for protein synthesis.
* Correspondence shouldt be addtressed to: E. T. Bucovaz, Ph. D., Department of Biochemistry, Univer-
sitv of Tennessee, Center for the Health SieLnces, 894 Union Avenue, Memphis, Tennessee 38163, U.S.A.INCORPORATION OF THN-CYSTEINE INTO PROTEIN
MATERIALS AND METHODS
Preparation of enzyme fraction.-An en-
zyme fraction was prepared from baker's
yeast by the method previously described
by Bucovaz et al. (1970) in which 15-36 g
(10% saturation) of ammonium sulphate
was added to 300 ml of the 105,000 g
supernatant fraction of a yeast homogenate.
After 24 h, the precipitate formed was
removed by centrifugation and discarded.
The supernatant fraction was adjusted to
60% saturation with ammonium sulphate,
followed by thorough mixing. After 2 h,
the mixture was centrifuged at 7700 g for
20 min. The supernatant layer was dis-
carded and the precipitate was dissolved
in 180 ml of 0-01 M Tris-HCl, pH 7-25,
resulting in a total volume of 240 to 260 ml.
This redissolved precipitate was termed the
" 60% extract " and was used in this in-
vestigation as the source of aminoacyl-RNA
synthetases.
Transfer RNA. Transfer RNA of baker's
yeast and the polynucleotides used in
this study were purchased from General
Biochemical Company, Chagrin Falls,
Ohio.
Preparation of ribosomes. The ribosomal
fraction was prepared by a modification
of the method described by Robinson and
Novelli (1962).
Preparation of [32P]-pyrophosphate.-The
[32P]K4P207 was prepared from carrier-free
[32P]-orthophosphate (New England Nuclear
Corporation, Boston, Mass.) by pyrolysis
(Jones et al., 1953).
Preparation of S-substituted cysteine.
THN-Cysteine was prepared by a modifica-
tion of the method of Boyland and Sims
(1960), in which the reaction temperature
was 37°C instead of 60TC, and the reaction
time was 30 min.
ATP-[32P] pyrophosphate exchange as-
say. The components of the assay mixture
were as follows: 60% extract containing
5 to 6 mg of protein; 5*0 mm MgCl2; 200 mm
Tris-HCl, pH 7-25; 6 mm of S-substituted
cysteine or 6 mM of one of the naturally-
occurring amino acids; 5 mm disodium ATP,
pH 7-25; 70 mm 2-mercaptoethanol; and
5 mM [32P]K4P207, pH 7*5. The total
volume in each tube was adjusted to 1-0 ml
with water. Additions to the reaction
mixtures are described in the legend to
Table I. The reaction mixtures were in-
cubated for 30 min at 37TC, and the reaction
was terminated by the addition of 1 ml of
10% trichloroacetic acid. The coagulated
protein was removed by centrifugation.
ATP present in the supernatant liquid was
adsorbed on to DARCO G-60 (Matheson,
Coleman and Bell, East Rutherford, N.J.),
and analysed according to the method
of Crane and Lipmann (1953) as modified
by DeMoss and Novelli (1956).
Assay of transfer activity.-The reaction
mixtures contained the following compo-
nents: 40 mg of tRNA; 100 mm Tris-HCl,
pH 7-25; 25 mm MgCl2; 2 mm disodium-
ATP; 0 5 mm EDTA; one of the radio-
actively labelled amino acids described in
the legend to Table II; 20 mm 2-mercapto-
ethanol; 0 05 ml of the 60% extract con-
taining 5 to 6 mg of protein; and water to
give a total volume of 1 ml. Tubes with
all components except ATP were prepared
as controls. The mixtures were incubated for
10 min at 37°C. The reaction was termin-
ated by immersing the tubes in an ice-
water-NaCl bath, and a 0-1 ml aliquot of
each incubation mixture was pipetted on
to 2-3-cm paper discs (Whatman No. 3
MM). The discs were dried, washed, and
assayed by a method similar to that de-
scribed by Holley et al. (1961) and Nishimura
and Novelli (1964).
Incorporation into ribosomal protein.-The
composition of reaction mixtures used to
study incorporation is described in the
legends to Tables III, IV and V.
The reaction mixtures were incubated
for 30 min at 37°C. Following incubation,
the reaction mixtures were diluted to 10 ml
with 0-1 M Tris-HCl, pH 7-25, and centrifuged
at 105,000 g for 60 min, to sediment the
ribosomes. The ribosomal particles were
washed according to the method ofSchneider
(1945) with 5% TCA, followed by extraction
with 500 TCA at 90°C for 15 min and with
ether-ethanol (1: 1, v/v). The ribosomal
pellets were dissolved in 3 ml of 80% formic
acid. An aliquot (0.1 ml) from each of
these solutions was assayed for protein
content and radioactivity.
Miscellaneous methods.-Orthophosphate
was determined by the method of Fiske and
SubbaRow (1925). Protein concentrations
were determined by the method of Lowry et
al. (1951). Radioactivity was measured in
a Nuclear Chicago liquid scintillation counter
with the use of the scintillation liquid
described by Bray (1960).
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RESULTS AND DISCUSSION
Previously we have reported that
THN-cysteine is activated and transferred
to tRNA by aminoacyl-tRNA synthetases
of baker's yeast in a similar manner to
the natural amino acids (Bucovaz et al.,
1966). The experimental results pre-
sented in Table I show the effect of
decarboxylated and N-acetylated deriva-
tives on the valine, isoleucine and THN-
cysteine-dependent ATP-[32P]PPi ex-
change activity catalysed by aminoacyl-
tRNA synthetases of baker's yeast. Stud-
ies with valine (Group I) and isoleucine
(Group II) were included for reasons
of comparison. As shown, the activation
of these 2 amino acids was competitively
inhibited by isobutylamine and 2-methyl-
butylamine, respectively. Also, as shown
in Group III, isobutylamine and 2-
methylbutylamine inhibit the activation
of THN-cysteine. Neither cysteamine
norN-acetyl-valinenor N-acetyl-isoleucine
affected the level of the valine, isoleucine
and THN-cysteine-dependent ATP-[32P]-
PPi exchange reaction. (The decarb-
oxylated and N-acetylated products of
the other naturally-occurring amino acids
did not have any effect on the system.)
Thus, the aminoacyl-RNA synthetases
responsible for the carboxyl activation
of valine and isoleucine appear to be
responsible for the carboxyl activation of
THN-cysteine.
The data in Table II show the effect
of decarboxylated or N-acetylated pro-
ducts on the acylation of tRNA with
valine, isoleucine and THN-cysteine. Only
the decarboxylated products inhibit their
corresponding amino acids. Transfer of
[35S] THN-cysteine to tRNA was in-
hibited by isobutylamine and 2-methyl-
butylamine. The N-acetylated products
of valine and isoleucine did not interfere
with the transfer of their respective
radioactive amino acids or with THN-
cysteine to tRNA. This was interpreted
as supportive evidence that the activation
and transfer of THN-cysteine is catalysed
by the valyl- and isoleucyl-RNA syn-
thetases and that the tRNAs involved
are those specific for valine and isoleucine.
In Group I of Table III, [35S]THN-
cysteine was the radioactive tracer.
[35S]THN-cysteinyl-tRNA was used in-
stead of [35S]THN-cysteine in Group II.
Experiments 1, 4 and 5 of each group
are controls. Experiment 1 of each
group represents the maximum level
of incorporation expected, whereas ex-
periments 4 and 5 represent the minimum
level.
As shown, a 30-fold addition of amines
of valine and isoleucine (Experiment 2
TABLE I.-Effect of Decarboxylated and N-acetylated Amino Acids
dependent ATP-[32P]PPi Exchange Assay
Reaction mixture
Group
no. Components
Valine + ATP + [32P]PPi
Valine + ATP + [32P]PPi
Valine + ATP + [32P]PPi
Valine + ATP + [32P]PPi
II Isoleucine + ATP + [32P]PPi
Isoleucine + ATP + [32P]PPi
Isoleucine + ATP + [32P]PPi
Isoleucine + ATP + [32P]PPi
III THN-Cysteine + ATP + [32P]PPi
THN-Cysteine + ATP + [32P]PPi
THN-Cysteine + ATP + [32P]PPi
THN-Cysteine + ATP + [32P]PPi
Additions
None
Isobutylamine
Cysteamine
N-Acetyl-valine
None
2-Methylbutylamine
Cysteamine
N-Acetyl-isoleucine
on the Amino Acid-
Net
t/min/,umol
PPi/30 min
None
Isobutylamine and 2-methylbutylamine
Cysteamine
N-Acetyl-valine and N-acetyl-isoleucine
113
38
149
155
83
2
77
80
31
12
33
25
The method of assay is described under " Materials and Methods ". Isobutylamine (the amine of
valine), 2-methylbutylamine (the amine of isoleucine), cysteamine, N-acetyl-valine and N-acetyl-isoleucine
were tested at concentrations of 12 mm.
Group~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~.
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TABLE II.-Effect ofDecarboxylated andN-acetylated Amino Acids on the Aminoacylation
oftRNA
Reaction mixture
t A
Components
[14C]Valine + tRNA + ATP
["4C]Valine + tRNA + ATP
[14C]Valine + tRNA + ATP
[14C]Valine + tRNA + ATP
[14C]Isoleucine + tRNA + ATP
[14C]Isoleucine + tRNA + ATP
[14CjIsoleucine + tRNA + ATP
[14C]Isoleucine + tRNA + ATP
[35S]THN-Cysteine + tRNA + ATP
[35S]THN-Cysteine + tRNA + ATP
[35S]THN-Cysteine + tRNA + ATP
[35S]THN-Cysteine + tRNA + ATP
Additions
None
Isobutylamine
Cysteamine
N-Acetyl-valine
None
2-Methylbutylamine
Cysteamine
N-Acetyl-isoleucine
None
2-Methylbutylamine and isobutylamine
Cysteamine
N-Acetyl-valine and N-acetyl-isoleucine
The reaction mixtures contained 0 4 jumol of [14C]valine (3 20 x 105 ct/min); 0-4 ,mol [14C]isoleucine
(3-55 x 105ct/min); or 0 5mol [35S]THN-cysteine (2-0 x 105ct/min). In addition, 12-0,umol iso-
butylamine, cysteamine, 2-methylbutylamine, N-acetyl-valine or N-acetyl-isoleuciine were added as in-
dicated. Other assay conditions are described under " Materials and Methods ".
TABLE III.-Incorporation ofTHN-cysteine into Protein
Incubation system
No. Components Additions
Group I
1 Complete system*
2 Complete system Isobutylamine and 2-methylbutylamine
3 Complete system Cysteamine
4 Omit energy + amine
5 Omit enzyme i amine
Group II
1 Complete systemt
2 Complete system Isobutylamine and 2-methylbutylamine
3 Complete system Cysteamine
4 Omit energy + amine
5 Omit enzyme ±amine
Radioactivity
incorporated
(ct/min/mg)
225
35
240
25
24
180
170
173
10
4
* Complete system: [35S]THN-cysteine, tRNA, ribosomes, ATP, GTP, PEP, 105,000 g soluble fraction
of baker's yeast.
t Complete system: [35S]THN-cysteinyl-tRNA, ribosomes, ATP, GTP, PEP, 105,000 g soluble fraction
of baker's yeast.
The reaction mixtures contained 10 mol phosphoenolpyruvate; 50 mg of pyruvate kinase; 10 mM
MgCl2; Omm GTP; 100mm Tris-HCI, pH 7-25; 0-5,umol [35S]THN-cysteine (2-0 x 105ct/min) or
approximately 0-02 jumol of [35S]THN-cysteinyl-tRNACYs (3-2 x 104 ct/min); 60% extract containing
5 mg of protein; 4-0 mg tRNA; a 30-fold addition of isobutylamine, 2-methylbutylamine and cysteamine
(where indicated) and 10 mg of ribosomal protein in a total volume of 1 ml. The assay procedure is
described under " Materials and Methods ".
of Group I) caused a marked reduction
in [35S]THN-cysteine incorporated into
ribosomal protein. The addition of cyste-
amine did not alter the level of [35S]THN-
cysteine incorporation. However, when
[35S]THN-cysteinyl-tRNA was used as
the source of radioactive arylcysteine
(Group II), the amines ofvaline, isoleucine
and cysteine did not have any effect
on the incorporation. It is well estab-
lished that the carboxyl activation of
natural amino acids is competitively
inhibited by their respective amines:
however, these amines do not inhibit
No.
1
2
3
4
1
2
3
4
1
2
3
4
Radioactivity
(ct/min)
477
82
473
482
516
24
477
492
200
22
195
203
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the incorporation into protein of their
respective amino acids once these amino
acids are esterified with tRNA. Thus,
the experiments of Table III provide
evidence that the amines of valine and
isoleucine compete only with THN-cys-
teine for their respective synthetases,
but do not effect transfer of the aryl-
cysteine from tRNA to protein.
The data in Table IV show results
of studies in which [35S]cysteine and
[35S]THN-cysteine are incorporated into
protein under various conditions. In the
first and second groups of experiments,
[35S]cysteine and [35S]THN-cysteine were
used, and in the third, fourth and fifth
groups of experiments, [35S]cysteinyl-
tRNACYs, [35S]THN-cysteinyl-tRNACYs
and [35S]THN-cysteinyl-tRNAval, lie were
used. The first experiment in each group
indicates the maximum level ofincorpora-
tion, whereas Experiment 4 of each
group represents the minimum level of
incorporation expected in a particular
group.
The addition of unlabelled cysteine
to Group I, and unlabelled cysteinyl-
tRNACYs to Group III, decreased the
level of incorporation of their radioactive
counterpart, whereas the addition of
valine and isoleucine to experiments
of Group I or valyl-tRNAval and iso-
leucyl-tRNAIle to experiments of Group
III did not have any effect on the level
of analogue incorporated into protein.
The addition of unlabelled cysteine to
experiments of Group II did not cause
a decrease in the level of incorporation
of [35S]THN-cysteine. The addition of
valine and isoleucine, however, decreased
the level of [35S]THN-cysteine incor-
porated, comparable to that of the zero
time control. In Group IV, an excess
of cysteinyl-tRNACY8 markedly reduced
the amount of radioactive [35S]THN-
cysteinyl-tRNACYS incorporated, but the
addition of valyl-tRNAval and isoleucyl-
tRNAIle did not alter the level of in-
corporation ofthe radioactive component.
In contrast, in Group V where a mixture
TABLE IV.-Transfer-RNA-directed Incorporation
Experiments Radioactivity
A ~ < incorporation
Group Radioactive tracer Additions (ct/min/mg)
I [35S]Cysteine None 803
Cysteine 98
Valine and isoleucine 780
None, zero time 107
II [35S]THN-Cysteine None 490
Cysteine 483
Valine and isoleucine 65
None, zero time 75
III [I35S]Cys-tRNACYs None 430
Cys-tRNACYs 135
Val-tRNAval and Ile-tRNAIle 443
None, zero time 51
IV [3IS]THN-Cys-tRNACYs None 450
Cys-tRNACYS 259
Val-tRNAval and Ile-tRNAIle 435
None, zero time 60
V [3,5S]THN-Cys-tRNAVal, Ile None 250
Cys tRNAcys 228
Val-tRNAval and Ile-tRNAIie 98
None, zero time 65
The reaction mixtures contained one of the following radioactive tracers (where indicated): 0-1 uzmol
[35S]cysteine (1-60 x 105ct/min); 0 5 ,mol [35S]THN-cysteine (2-0 x 105ct/min); 0 02 umol of [35S]-
cysteinyl-tRNACYS (3-2 x 104 ct/min); 0-02 ,umol of [35S]THN-cysteinyl-tRNACYs (3-2 x 104 ct/min);
0 04 Mmol of [35S]THN-cysteinyl-tRNAval Iie (3 - 6 x 104 ct/min). In addition, approximately a 30-fold
addition of each unlabelled component was added (where indicated). Other components of the system
were the same as described under Table III.
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of [35S]THN-cysteinyl-tRNAVal, lie was
used as the radioactive tracer, the addition
of valyl- and isoleucyl-tRNAs caused
a decrease in the level of radioactivity
incorporated. Cysteinyl-tRNACYs in this
case did not have an effect on the level
of [35S]THN-cysteine incorporated.
These observations supportthe premise
that THN-cysteine is transferred to the
valyl- and isoleucyl-tRNAs, and hence
is incorporated into protein as a substitute
for these natural amino acids, whereas,
THN-cysteine esterified with tRNAcYs
is incorporated in the position normally
occupied by cysteine.
The effect of polynucleotides on the
incorporation reaction is found in the
series of experiments presented in Table
V. In these experiments the incorpora-
tion of THN-cysteine into protein was
studied in the presence and absence
of polynucleotides.
The Experiment 1 of each group
contained all necessary components for
the reaction, including the synthetic
polynucleotide. In Experiment 2 of each
group, the complementary polynucleotide
was omitted from the reaction mixture.
Experiment 3 in each group was the zero
time control.
The addition of the appropriate poly-
nucleotide to the reaction mixtures of
Groups I, II and III, as expected, stimu-
lates the incorporation of the natural
amino acid into protein. Poly-UG stimu-
lated the incorporation of both cysteine
and valine, because anticodons of
tRNACYs and tRNAval are UGU and
GUU, respectively. Poly-AU stimulates
the incorporation of isoleucine. In each
case, in Groups I, II and III, the omission
of the appropriate polynucleotide from
the reaction mixture (Experiment 2)
significantly reduced the level of the
natural amino acid incorporated into
protein. Groups IV, V and VI show
that the level of incorporation of [35S]-
THN-cysteine esterified with tRNACYs,
tRNAIle and tRNAval is increased when-
ever the appropriate polynucleotide is
present as a component of the reaction
mixture. Also in these experiments, the
absence of the complementary poly-
nucleotide (Experiment 2) results in a
significant decrease in the level of [35S]-
THN-cysteine incorporated.
TABLE V.-Effect ofPolynucleotides on the Incorporation Reaction
Incubation system Radioactivity
Group , incorporated
no. Radioactive tracer Additions or deletions (ct/min/mg)
I [35S]Cysteine-tRNACYS
II [l4C]Ile-tRNAIle
III [l4C]Val-tRNAval
IV [3SS]THN-Cysteine-tRNACYs
V [35S]THN-Cysteine-tRNAIle
VI [35S]THN-Cysteine-tRNAval
None
-Poly UG
None, zero time
None
-Poly AU
None, zero time
None
-Poly UG
None, zero time
None
-Poly UG
None, zero time
None
-Poly AU
None, zero time
None
-Poly UG
None, zero time
The reaction mixtures were the same as described under Table III, except that 0 * 3 mg of each poly-
nucleotide was added (where indicated); and approximately 0-02 ,zmol of each radioactive tracer was
used. The ribosomal fraction was washed x 3 with 0-I M Tris-HCl, pH 7-25, to remove endogenous
mRNA prior to use in this group of experiments.
443
151
99
600
203
71
420
137
63
437
143
83
297
195
87
390
143
74
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Therefore, it would appear that the
site of incorporation of THN-cysteine
into protein depends on whether THN-
cysteine is esterified with tRNACYS or
tRNAIle and tRNAVal. If 1,2-epoxy-
THN reacts with cysteinyl-tRNACYs, it
should substitute for cysteine in protein.
If, however, the 1,2-epoxy-THN reacts
with cysteine not esterified with tRNACYs
to form THN-cysteine, this S-substituted
cysteine is activated by the isoleucyl-
and valyl-tRNA synthetases, and would
be esterified with tRNAIle and tRNAval.
Consequently, under this condition, THN-
cysteine would substitute for isoleucine
and valine rather than cysteine. Thus,
THN-cysteine is incorporated into protein
in the same manner as the natural
amino acids, and can be substituted
for either cysteine or isoleucine and
valine, depending on whether cysteine
is free in the cell or esterified with
tRNACY8.
THN-Cysteine has been used as a
model compound to investigate the mech-
anism by which cyclic hydrocarbons are
incorporated into protein. Presumably,
the epoxides of phenanthrene, benz-
anthracene, dibenzanthracene and methyl
benzanthracene, which were previously
shown to be incorporated into protein
(Bucovaz et al., 1970) as hydrocarbon-
cysteine conjugates, are incorporated in
a manner similar to THN-cysteine.
Molinary and Wood (1971) and Frendo
and Wood (1972) have demonstrated
the incorporation S-(9-hydroxy-9,10-di-
hydro-10-phenanthryl)-L-cysteine into f8-
galactosidase of E. coli and rabbit haemo-
globin, respectively. The inhibitoryeffect
of these arylcysteines was partially re-
versed by the natural amino acids, pre-
viously shown by Bucovaz et al. (1970)
to be competitive with these particular
S-substituted cysteines. Also Frendo and
Wood (1974) reported that certain aro-
matic hydrocarbon cysteine conjugates
inhibited the growth of Pediococcus cere-
visiae. The inhibitory effects in this
organism were also partially reversed
by amino acids previously shown to be
competitive with the analogue in an in
vitro rat liver system.
At present, however, insufficient evi-
dence is available to support a positive
relationship between arylcysteine incor-
poration into protein and significant
alterations in the cellular function of
these proteins. Nevertheless, alterations
in the primary structure of cellular
proteins, resulting from the incorporation
of arylcysteines, could alter the integrity
of the cell.
This investigation was supported in
part by USPHS Research Grant
AM-09131.
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